IN VITRO MODEL OF POLARIZED TROPHOBLAST
极化滋养细胞的体外模型
基本信息
- 批准号:3147279
- 负责人:
- 金额:$ 20.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-09-30 至 1994-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS antiAIDS agent antibody receptor apical membrane basolateral membrane congenital infection drug adverse effect drug metabolism electron microscopy gene expression hormone biosynthesis human immunodeficiency virus human tissue immunoglobulin G inulin membrane permeability membrane potentials model model design /development mother /embryo /fetus nutrition nutrition related tag placenta placental transfer tissue /cell culture transferrin trophoblast
项目摘要
An in vitro model of trophoblast will be developed which will permit
research into many aspects of placental function as it relates to
maternal HIV infection. The trophoblast will be maintained in tissue
culture in a bicameral chamber providing independent access to the apical
(maternal) and basal (fetal) surfaces of the trophoblast. The criteria
for a successful preparation will include tests of barrier function
(electrical resistance, restricted transfer of inulin and other
molecules, microscopic evidence of a continuous monolayer) and tests of
polarity (differentiation into apical and basolateral domains on EM,
directed extrusion of virions and preferential uptake of transferrin from
the apical surface). Three cell types will be used for the model:
transformed trophoblast and primary trophoblast isolated from term and
from first trimester placenta. The models will be subjected to tests
designed to investigate two of its major roles: the transfer of nutrients
to the fetus and the synthesis and secretion of hormones for the
maintenance of pregnancy. The potential toxicity of anti-HIV drugs will
be explored by exposing trophoblast to the drug and then re-testing its
function. The transfer and metabolism of the HIV drugs will also be
studied taking advantage of the polarity of the model. Concurrently the
usefulness of the model for the study of immunological questions
concerning AIDS and other intrapartum infections will be explored. The
expression of Fc receptors and the transepithelial transfer of IgG will
be measured. Introduction of Fc receptors into trophoblast by
recombinant techniques will be undertaken to amplify this function if
necessary. The model will be applied to questions pertinent to the
manifestation of disease in the fetus such as the transfer of specific
antibodies, of viral antigens and infectious agents and of complexes of
antigens and antibodies.
将开发一种滋养层的体外模型,
研究胎盘功能的许多方面,
孕产妇艾滋病毒感染。 滋养层将保持在组织中
在两院制培养室中培养,提供独立的根尖通道
(母体)和基底(胎儿)表面的滋养层。 的标准
成功的准备将包括屏障功能的测试
(电阻,菊粉和其他限制转移
分子,连续单层的微观证据)和
极性(在EM上分化为顶端和基底外侧区域,
病毒体的定向挤出和转铁蛋白的优先摄取
顶面)。 模型将使用三种细胞类型:
转化的滋养层和初级滋养层分离自足月妊娠,
从孕早期胎盘中提取的 这些模型将接受测试
旨在研究它的两个主要作用:营养物质的转移
对胎儿和合成和分泌激素的
维持妊娠。 抗艾滋病毒药物的潜在毒性将
通过将滋养层暴露于药物,然后重新测试其
功能 艾滋病毒药物的转移和代谢也将是
利用模型的极性进行研究。 兼任
免疫学问题研究模型的实用性
关于艾滋病和其他产时感染的问题将进行探讨。 的
Fc受体的表达和IgG的跨上皮转移将
被衡量。 Fc受体在滋养层细胞中的表达
将采用重组技术来扩增该功能,如果
必要 该模型将被应用于有关的问题,
胎儿疾病的表现,如特定的
抗体、病毒抗原和感染因子的抗体以及
抗原和抗体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH DANCIS其他文献
JOSEPH DANCIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH DANCIS', 18)}}的其他基金
相似海外基金
ACTG 303--RISK STATUS FOR DISEASE PROGRESSION AND RESPONSE TO ANTIAIDS AGENT
ACTG 303--疾病进展的风险状态和抗艾滋病药物的反应
- 批准号:
6114298 - 财政年份:1998
- 资助金额:
$ 20.29万 - 项目类别:
ACTG 303--RISK STATUS FOR DISEASE PROGRESSION AND RESPONSE TO ANTIAIDS AGENT
ACTG 303--疾病进展的风险状态和抗艾滋病药物的反应
- 批准号:
6275533 - 财政年份:1997
- 资助金额:
$ 20.29万 - 项目类别: